P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Emerging evidence on the use of biological agents in severe asthma

P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment

Free

Online download statistics by month:

Online download statistics by month: January 2021 to March 2024

	Abstract	Full	Pdf
Jan 2021	45	0	1
Feb 2021	42	0	3
Mar 2021	34	0	1
Apr 2021	66	0	2
May 2021	19	0	1
Jun 2021	1	0	0
Jul 2021	0	0	1
Sep 2021	0	0	2
Oct 2021	42	0	0
Nov 2021	48	0	2
Dec 2021	14	0	0
Jan 2022	42	0	1
Feb 2022	44	0	3
Mar 2022	22	0	1
Apr 2022	34	0	0
May 2022	60	0	2
Jun 2022	40	0	0
Jul 2022	26	0	1
Aug 2022	40	0	0
Sep 2022	30	0	5
Oct 2022	14	0	0
Nov 2022	28	0	0
Dec 2022	26	0	0
Jan 2023	32	0	2
Feb 2023	38	0	0
Mar 2023	25	0	0
Apr 2023	42	0	0
May 2023	18	0	0
Jun 2023	36	0	0
Jul 2023	31	0	0
Aug 2023	34	0	0
Sep 2023	39	0	3
Oct 2023	37	0	0
Nov 2023	34	0	0
Dec 2023	38	0	0
Jan 2024	16	0	0
Feb 2024	10	0	1
Mar 2024	30	0	1
Total	1177	0	33